000 | 01676 a2200517 4500 | ||
---|---|---|---|
005 | 20250515045917.0 | ||
264 | 0 | _c20070208 | |
008 | 200702s 0 0 eng d | ||
022 | _a1720-8386 | ||
024 | 7 |
_a10.1007/BF03347374 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSalvatori, R | |
245 | 0 | 0 |
_aGH response to hypoglycemia and clonidine in the GH-releasing hormone resistance syndrome. _h[electronic resource] |
260 |
_bJournal of endocrinological investigation _cOct 2006 |
||
300 |
_a805-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
650 | 0 | 4 | _aBody Height |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aClonidine _xpharmacology |
650 | 0 | 4 |
_aDwarfism, Pituitary _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGrowth Hormone-Releasing Hormone _xgenetics |
650 | 0 | 4 |
_aHuman Growth Hormone _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
650 | 0 | 4 |
_aInsulin _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aSyndrome |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aSerpa, M G | |
700 | 1 | _aParmigiani, G | |
700 | 1 | _aBritto, A V O | |
700 | 1 | _aOliveira, J L M | |
700 | 1 | _aOliveira, C R P | |
700 | 1 | _aPrado, C M | |
700 | 1 | _aFarias, C T | |
700 | 1 | _aAlmeida, J C | |
700 | 1 | _aVicente, T A R | |
700 | 1 | _aAguiar-Oliveira, M H | |
773 | 0 |
_tJournal of endocrinological investigation _gvol. 29 _gno. 9 _gp. 805-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF03347374 _zAvailable from publisher's website |
999 |
_c16686651 _d16686651 |